Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Sep 28;6:33963. doi: 10.1038/srep33963

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2016, The Author(s)

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

PMC Copyright notice

(A) Liquiritin (LQ) can alleviate the arrhythmia caused by aconitine (AC). (a–d) The arrhythmia monitored in the ECG after administration of aconitine and liquiritin. (e) Onset time and (f) dosage of arrhythmia after continuous administration of aconitine and liquiritin under PB, VT, and CA. For e and f, solid bars represent AC treatment alone and open bars represent AC + LQ co-treatment. (B) 6-gingerol can elevate the cardiac functions of aconitine by hemodynamic indexes. (a) LVEDP, (b) HR, (c) dp/dt_max, (d) SBP, DBP, MBP and LVSP after administration of aconitine (5 ug/kg) and 6-gingerol (70 ug/kg).) *p < 0.05, **p < 0.01 vs aconitine group. Data shows as mean ± SD.